{"entity":{"type":"insider","cik":"0001762583","url":"/insider/0001762583","json_url":"/insider/0001762583.json","name":"Klein Lawrence Otto","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":29,"n_filings":7,"first":"2019-07-12","last":"2026-06-15","span_basis":"filed_date"},"name_variants":[{"name":"Klein Lawrence Otto","source":"filing","n_filings":7,"first_seen":"2019-07-12","last_seen":"2026-06-15"}],"transactions":[{"id":5914941,"accession":"0000907654-26-000062","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000907654-26-000062","line_url":"/filing/0000907654-26-000062#line-1","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"Oruka Therapeutics, Inc.","issuer_ticker":"ORKA","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":"0001762583","owner_name":"Klein Lawrence Otto","owner_display_name":"Klein Lawrence Otto","owner_url":"/insider/0001762583","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1729.0,"shares_display":"1,729","price_per_share":69.69,"price_display":"69.69","price_state":"stated","total_value":120494.01,"total_display":"120,494.01","total_whole":"120,494","shares_owned_after":925580.0,"shares_owned_after_display":"925,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-15","filed_date":"2026-06-15","scope":"insider"},{"id":5901511,"accession":"0000907654-26-000033","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000907654-26-000033","line_url":"/filing/0000907654-26-000033#line-1","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"Oruka Therapeutics, Inc.","issuer_ticker":"ORKA","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":"0001762583","owner_name":"Klein Lawrence Otto","owner_display_name":"Klein Lawrence Otto","owner_url":"/insider/0001762583","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1729.0,"shares_display":"1,729","price_per_share":41.3,"price_display":"41.30","price_state":"stated","total_value":71407.7,"total_display":"71,407.70","total_whole":"71,408","shares_owned_after":927309.0,"shares_owned_after_display":"927,309","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-16","filed_date":"2026-03-17","scope":"insider"},{"id":5379548,"accession":"0001209191-21-023069","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-21-023069","line_url":"/filing/0001209191-21-023069","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001762583","owner_name":"Klein Lawrence Otto","owner_display_name":"Klein Lawrence Otto","owner_url":"/insider/0001762583","role":"Officer (CBO & COO)","role_mark":"O","role_mark_label":"Officer (CBO & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & COO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":128.0524,"price_display":"128.05","price_state":"stated","total_value":12805240.0,"total_display":"12,805,240.00","total_whole":"12,805,240","shares_owned_after":13050.0,"shares_owned_after_display":"13,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-23","filed_date":"2021-03-25","scope":"insider","n_lines":2},{"id":5243209,"accession":"0001209191-21-004458","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001209191-21-004458","line_url":"/filing/0001209191-21-004458","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001762583","owner_name":"Klein Lawrence Otto","owner_display_name":"Klein Lawrence Otto","owner_url":"/insider/0001762583","role":"Officer (CBO & COO)","role_mark":"O","role_mark_label":"Officer (CBO & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & COO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":215.197584,"price_display":"215.20","price_state":"stated","total_value":5379939.6,"total_display":"5,379,939.60","total_whole":"5,379,940","shares_owned_after":20703.0,"shares_owned_after_display":"20,703","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-20","scope":"insider","n_lines":13},{"id":2436910,"accession":"0001209191-20-039086","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-20-039086","line_url":"/filing/0001209191-20-039086#line-11","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001762583","owner_name":"Klein Lawrence Otto","owner_display_name":"Klein Lawrence Otto","owner_url":"/insider/0001762583","role":"Officer (CBO & COO)","role_mark":"O","role_mark_label":"Officer (CBO & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & COO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4912.0,"shares_display":"4,912","price_per_share":75.1776,"price_display":"75.18","price_state":"stated","total_value":369272.3712,"total_display":"369,272.37","total_whole":"369,272","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-25","filed_date":"2020-06-26","scope":"insider"},{"id":2436904,"accession":"0001209191-20-039086","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-20-039086","line_url":"/filing/0001209191-20-039086","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001762583","owner_name":"Klein Lawrence Otto","owner_display_name":"Klein Lawrence Otto","owner_url":"/insider/0001762583","role":"Officer (CBO & COO)","role_mark":"O","role_mark_label":"Officer (CBO & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & COO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65088.0,"shares_display":"65,088","price_per_share":75.93245681846116,"price_display":"75.93","price_state":"stated","total_value":4942291.7494,"total_display":"4,942,291.75","total_whole":"4,942,292","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-24","filed_date":"2020-06-26","scope":"insider","n_lines":7},{"id":2879830,"accession":"0001209191-20-028839","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-028839","line_url":"/filing/0001209191-20-028839","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001762583","owner_name":"Klein Lawrence Otto","owner_display_name":"Klein Lawrence Otto","owner_url":"/insider/0001762583","role":"Officer (CBO & COO)","role_mark":"O","role_mark_label":"Officer (CBO & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & COO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":60.3988232,"price_display":"60.40","price_state":"stated","total_value":1509970.58,"total_display":"1,509,970.58","total_whole":"1,509,971","shares_owned_after":20682.0,"shares_owned_after_display":"20,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-11","filed_date":"2020-05-13","scope":"insider","n_lines":2},{"id":8224903,"accession":"0000899243-19-019535","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-019535","line_url":"/filing/0000899243-19-019535#line-4","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001762583","owner_name":"Klein Lawrence Otto","owner_display_name":"Klein Lawrence Otto","owner_url":"/insider/0001762583","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8421.0,"shares_display":"8,421","price_per_share":50.0144,"price_display":"50.01","price_state":"stated","total_value":421171.2624,"total_display":"421,171.26","total_whole":"421,171","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-11","filed_date":"2019-07-12","scope":"insider"},{"id":8224898,"accession":"0000899243-19-019535","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-019535","line_url":"/filing/0000899243-19-019535#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001762583","owner_name":"Klein Lawrence Otto","owner_display_name":"Klein Lawrence Otto","owner_url":"/insider/0001762583","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11579.0,"shares_display":"11,579","price_per_share":50.02,"price_display":"50.02","price_state":"stated","total_value":579181.58,"total_display":"579,181.58","total_whole":"579,182","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-10","filed_date":"2019-07-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":29,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":29,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":29},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000907654","name":"Oruka Therapeutics, Inc.","url":"/issuer/0000907654","role":"Director, Officer (Chief Executive Officer)","n_filings":2,"first_seen":"2026-03-17","last_seen":"2026-06-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001674416","name":"CRISPR Therapeutics AG","url":"/issuer/0001674416","role":"Officer (CBO & COO)","n_filings":5,"first_seen":"2019-07-12","last_seen":"2021-03-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001762583","retrieved_at":"2026-08-23T17:22:58+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}